GTF3C1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.17743617475708E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.14050033043156E-10 |
Normal-vs-Stage2 |
9.08949582267837E-11 |
Normal-vs-Stage3 |
1.19760001915381E-09 |
Normal-vs-Stage4 |
1.20379999968279E-07 |
Stage1-vs-Stage2 |
5.862300E-03 |
Stage1-vs-Stage3 |
6.887500E-02 |
Stage1-vs-Stage4 |
1.902250E-01 |
Stage2-vs-Stage3 |
3.351400E-01 |
Stage2-vs-Stage4 |
3.399600E-01 |
Stage3-vs-Stage4 |
9.415800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.00302013758846E-12 |
Normal-vs-AfricanAmerican |
1.019230E-04 |
Normal-vs-Asian |
1.585840E-01 |
Caucasian-vs-AfricanAmerican |
1.349210E-01 |
Caucasian-vs-Asian |
2.789000E-01 |
AfricanAmerican-vs-Asian |
6.369800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.99840144432528E-15 |
Normal-vs-Female |
1.52156999999598E-05 |
Male-vs-Female |
2.773100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.81400000000198E-05 |
Normal-vs-Age(41-60Yrs) |
6.31890000324375E-08 |
Normal-vs-Age(61-80Yrs) |
1.78634884662188E-12 |
Normal-vs-Age(81-100Yrs) |
6.06990000040497E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.173400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.001600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.223400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.738190E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.397380E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.288600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.287600E-01 |
Normal-vs-Grade 2 |
1.78029813113767E-11 |
Normal-vs-Grade 3 |
6.94569957104818E-10 |
Normal-vs-Grade 4 |
5.89870374767543E-11 |
Grade 1-vs-Grade 2 |
1.727520E-02 |
Grade 1-vs-Grade 3 |
7.018500E-03 |
Grade 1-vs-Grade 4 |
1.459780E-03 |
Grade 2-vs-Grade 3 |
6.241200E-01 |
Grade 2-vs-Grade 4 |
2.556800E-01 |
Grade 3-vs-Grade 4 |
4.977800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.64694949187106E-12 |
Normal-vs-ccB subtype |
3.66770003257244E-09 |
ccA subtype-vs-ccB subtype |
8.117200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.18760034928789E-10 |
Normal-vs-N1 |
1.158310E-02 |
N0-vs-N1 |
4.639000E-01 |
|
|